PDF(Pubmed)
Abstract：
Rapid growing mycobacteria have been increasingly recognized as pathogens, both in immunocompromised and immunocompetent population, and their incidence has increased over the last decade significantly. Pulmonary infections are the most common, however, any organ can be affected. The treatment of these infections is costly, prolonged, and often antimicrobial resistance poses a significant challenge to a successful outcome. The source control together with antimicrobials is the cornerstone of treatment. We report a case series of 3 patients with extrapulmonary rapid growing mycobacterial infections in whom the successful treatment was achieved with source control alone.
摘要：
快速生长的分枝杆菌越来越被认为是病原体，在免疫功能低下和免疫功能正常的人群中，在过去的十年中，它们的发病率显著增加。肺部感染是最常见的,然而,任何器官都可能受到影响。这些感染的治疗费用很高，延长,并且通常抗菌素耐药性对成功的结果构成了重大挑战。源控制与抗微生物药物一起是治疗的基石。我们报告了一系列3例肺外快速生长的分枝杆菌感染患者，其中仅通过源控制即可成功治疗。
